Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 25.6435.7730.8923.5130.67

What is the latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 25.64 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202625.64
Mar202535.77
Mar202430.89
Mar202323.51
Mar202230.67

How is EV/Core EBITDA of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 25.64
-28.32
Mar2025 35.77
15.80
Mar2024 30.89
31.39
Mar2023 23.51
-23.35
Mar2022 30.67 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹47,216.0 Cr -3.1% -10.3% 5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,276.0 Cr -0.3% -3.1% 12.8% Stock Analytics
DIVIS LABORATORIES ₹251,531.0 Cr -1.3% 2.2% 57.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,957.0 Cr -1.3% -2.4% 33.3% Stock Analytics
CIPLA ₹111,729.0 Cr 0.2% -2.5% -9.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,335.0 Cr 3.3% 6.1% -6.5% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

-3.1%

-10.3%

5%

SENSEX

-2.7%

-5.7%

-11.7%


You may also like the below Video Courses